{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:54:13Z","timestamp":1791323653220,"version":"4.3.1"},"reference-count":189,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jceh.2026.103599","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:55:27Z","timestamp":1782143727000},"page":"103599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Three Dimensional Biomimetic Liver Models to Reconstitute Metabolic Dysfunction-Associated Steatohepatitis (MASH) In Vitro: Hope and Reality"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-0562","authenticated-orcid":false,"given":"Saeedeh","family":"Zare Jalise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-8549","authenticated-orcid":false,"given":"Sina","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Fath-Bayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2026.103599_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/nu16050626","article-title":"Metabolic dysfunction-associated steatotic liver disease in a dish: human precision-cut liver slices as a platform for drug screening and interventions","volume":"16","author":"Li","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2026.103599_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.jceh.2026.103599_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/liv.14910","article-title":"Natural history of NASH","volume":"41","author":"Armandi","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2026.103599_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2026.103599_bib5","first-page":"56","article-title":"Tracking of intraperitoneally and direct intrahepatic administered mesenchymal stem cells expressing miR-146a-5p in mice hepatic tissue","volume":"4","author":"Fath-Bayati","year":"2020","journal-title":"Health Biotechnol Biopharm"},{"key":"10.1016\/j.jceh.2026.103599_bib6","first-page":"367","article-title":"Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease","volume":"22","author":"Aasadollahei","year":"2023","journal-title":"EXCLI J"},{"key":"10.1016\/j.jceh.2026.103599_bib7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s42003-023-04710-8","article-title":"Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease","volume":"6","author":"Yang","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jceh.2026.103599_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","article-title":"In vitro models for the study of liver biology and diseases: advances and limitations","volume":"15","author":"Kaur","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103599_bib9","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1039\/D1BM01872H","article-title":"In vitro functional models for human liver diseases and drug screening: beyond animal testing","volume":"11","author":"Paradiso","year":"2023","journal-title":"Biomater Sci"},{"key":"10.1016\/j.jceh.2026.103599_bib10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/cells9040964","article-title":"Human liver spheroids as a model to study aetiology and treatment of hepatic fibrosis","volume":"9","author":"Hurrell","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jceh.2026.103599_bib11","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1039\/C5LC00611B","article-title":"3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip","volume":"15","author":"Lee","year":"2015","journal-title":"Lab Chip"},{"key":"10.1016\/j.jceh.2026.103599_bib12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/mi13030428","article-title":"Microfluidic Organ-on-a-Chip devices for liver disease modeling in vitro","volume":"13","author":"Kanabekova","year":"2022","journal-title":"Micromachines"},{"key":"10.1016\/j.jceh.2026.103599_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/hep.31106","article-title":"Liver-on-a-Chip models of fatty liver disease","volume":"71","author":"Hassan","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103599_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.574047","article-title":"Liver organoids: recent developments, limitations and potential","volume":"8","author":"Harrison","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jceh.2026.103599_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/bioengineering8110185","article-title":"3D hepatic organoid-based advancements in LIVER tissue engineering","volume":"8","author":"Panwar","year":"2021","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.jceh.2026.103599_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13287-025-04314-5","article-title":"Genome editing of TXNIP in human pluripotent stem cells for the generation of hepatocyte-like cells and insulin-producing islet-like aggregates","volume":"16","author":"Traini","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jceh.2026.103599_bib17","first-page":"141","article-title":"Direct differentiation of human primary fibroblast into hematopoietic-like stem cells; A new way without viral transduction","volume":"22","author":"Habibi","year":"2020","journal-title":"Cell J"},{"key":"10.1016\/j.jceh.2026.103599_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119373","article-title":"Liver bioengineering: recent trends\/advances in decellularization and cell sheet technologies towards translation into the clinic","volume":"276","author":"Asadi","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.jceh.2026.103599_bib19","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1007\/s00204-018-2280-2","article-title":"3D human liver tissue from pluripotent stem cells displays stable phenotype in vitro and supports compromised liver function in vivo","volume":"92","author":"Rashidi","year":"2018","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jceh.2026.103599_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103549","article-title":"In vitro models for non-alcoholic fatty liver disease: emerging platforms and their applications","volume":"25","author":"Ramos","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jceh.2026.103599_bib21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00018-017-2713-8","article-title":"Liver cell therapy: is this the end of the beginning?","volume":"75","author":"Alwahsh","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jceh.2026.103599_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202200264","article-title":"Toward 3D-Bioprinted models of the liver to boost drug development","volume":"22","author":"Guagliano","year":"2022","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.jceh.2026.103599_bib23","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.3390\/jcm10204673","article-title":"Defining NASH from a multi-omics systems biology perspective","volume":"10","author":"Niu","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2026.103599_bib24","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1111\/liv.15025","article-title":"Zonation in NASH\u2013A key paradigm for understanding pathophysiology and clinical outcomes","volume":"41","author":"Steinman","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2026.103599_bib25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/metabo11100694","article-title":"Contribution of metabolomics to the understanding of NAFLD and NASH syndromes: a systematic review","volume":"11","author":"Piras","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jceh.2026.103599_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12015-025-11001-8","article-title":"Liver regeneration: Polyploidy and cellular senescence as potential regulators","volume":"22","author":"Zare","year":"2026","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.jceh.2026.103599_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111846","article-title":"Diabetes as a risk factor for MASH progression","volume":"217","author":"Gancheva","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jceh.2026.103599_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2026.1748835","article-title":"Clinical biomarkers and biosensors for early detection of metabolic dysfunction-associated steatohepatitis (MASH): a translational perspective","volume":"14","author":"Arshad","year":"2026","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jceh.2026.103599_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3892\/etm.2026.13090","article-title":"Senescent hepatic stellate cells drive inflammation and disease progression in MASH","volume":"31","author":"Han","year":"2026","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jceh.2026.103599_bib30","article-title":"Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASH","volume":"45","author":"Li","year":"2026","journal-title":"Cell Rep"},{"key":"10.1016\/j.jceh.2026.103599_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186420","article-title":"MASH: the nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"Steinberg","year":"2025","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jceh.2026.103599_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1720780","article-title":"Multiorgan crosstalk in MASLD\/MASH: from hepatic pathogenesis to systemic complications","volume":"16","author":"Bai","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jceh.2026.103599_bib33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tem.2025.09.004","article-title":"Mechanisms and therapeutic insights into MASH-associated fibrosis","volume":"37","author":"Zhu","year":"2026","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.jceh.2026.103599_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/1350178X.2022.2063925","article-title":"Nash meets Samuelson: the comparative-statics interpretation of Nash equilibrium","volume":"30","author":"Hudik","year":"2023","journal-title":"J Econ Methodol"},{"key":"10.1016\/j.jceh.2026.103599_bib35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jgm.920","article-title":"Mechanism of plasmid delivery by hydrodynamic tail vein injection. II. Morphological studies","volume":"8","author":"Budker","year":"2006","journal-title":"J Gene Med"},{"key":"10.1016\/j.jceh.2026.103599_bib36","article-title":"Research advances in the diagnosis and treatment of MASLD\/MASH","volume":"57","author":"Wang","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.jceh.2026.103599_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103599_bib38","series-title":"Clinical Epidemiology and Disease Burden of Nonalcoholic Fatty Liver Disease","author":"Perumpail","year":"2017"},{"key":"10.1016\/j.jceh.2026.103599_bib39","first-page":"149","article-title":"Prevalence of non-alcoholic fatty liver disease and its related factors in Iran","volume":"7","author":"Moghaddasifar","year":"2016","journal-title":"Int J Organ Transplant Med"},{"key":"10.1016\/j.jceh.2026.103599_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103599_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103599_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jbiotec.2025.01.019","article-title":"An in vitro 3D spheroid model with liver steatosis and fibrosis on microwell arrays for drug efficacy evaluation","volume":"399","author":"Chen","year":"2025","journal-title":"J Biotechnol"},{"key":"10.1016\/j.jceh.2026.103599_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/toxsci\/kfaf132","article-title":"In vitro models of the male reproductive system: applications for developmental and reproductive toxicology","volume":"208","author":"Hansen","year":"2025","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jceh.2026.103599_bib44","article-title":"In vitro models of the small intestine for studying intestinal diseases","volume":"12","author":"Jung","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jceh.2026.103599_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1442752","article-title":"Integrating text mining with network models for successful target identification: in vitro validation in MASH-induced liver fibrosis","volume":"15","author":"Venhorst","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jceh.2026.103599_bib46","article-title":"A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis","volume":"18","author":"Li","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2026.103599_bib47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1124\/dmd.115.067769","article-title":"Determination of human hepatocyte intrinsic clearance for slowly metabolized compounds: Comparison of a primary hepatocyte\/stromal cell Co-culture with plated primary hepatocytes and HepaRG","volume":"44","author":"Bonn","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jceh.2026.103599_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42785-9","article-title":"Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening","volume":"13","author":"Cottier","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2026.103599_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01951-7","article-title":"A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates","volume":"11","author":"Strobel","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2026.103599_bib50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/17425255.2022.2122810","article-title":"Modeling drug-induced liver injury: current status and future prospects","volume":"18","author":"Di Zeo-Sanchez","year":"2022","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jceh.2026.103599_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00204-021-03181-2","article-title":"Particulate and drug-induced toxicity assessed in novel quadruple cell human primary hepatic disease models of steatosis and pre-fibrotic NASH","volume":"96","author":"Kermanizadeh","year":"2022","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jceh.2026.103599_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911428","article-title":"In vitro models for studying chronic drug-induced liver injury","volume":"23","author":"Donato","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103599_bib53","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000585","article-title":"Modeling metabolic-associated steatohepatitis with human pluripotent stem cell-derived liver organoids","volume":"8","author":"Wu","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2026.103599_bib54","article-title":"Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: challenges and opportunities","volume":"17","author":"Silva","year":"2025","journal-title":"World J Stem Cell"},{"key":"10.1016\/j.jceh.2026.103599_bib55","article-title":"Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2026.103599_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13465","article-title":"In vitro construction of liver organoids with biomimetic lobule structure by a multicellular 3D bioprinting strategy","volume":"56","author":"Jian","year":"2023","journal-title":"Cell Prolif"},{"key":"10.1016\/j.jceh.2026.103599_bib57","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000105","article-title":"Liver organoids: established tools for disease modeling and drug development","volume":"7","author":"Sun","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2026.103599_bib58","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3350\/cmh.2022.0428","article-title":"A decade of liver organoids: advances in disease modeling","volume":"29","author":"Liu","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2026.103599_bib59","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.3390\/ijms24054529","article-title":"Liver organoids as an In vitro model to study primary liver cancer","volume":"24","author":"De Siervi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103599_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231154090","article-title":"Updates on organoid model for the study of liver cancer","volume":"22","author":"El-Khobar","year":"2023","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.jceh.2026.103599_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1133534","article-title":"Modeling human liver organ development and diseases with pluripotent stem cell-derived organoids","volume":"11","author":"Ouchi","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jceh.2026.103599_bib62","series-title":"Liver Organoid Potential Application for Hepatitis E Virus Infection. Hepatitis E Virus","first-page":"133","author":"Xiang","year":"2023"},{"key":"10.1016\/j.jceh.2026.103599_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202400322","article-title":"Exploiting the potential of decellularized extracellular matrix (ECM) in tissue engineering: a review study","volume":"25","author":"Brouki Milan","year":"2025","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.jceh.2026.103599_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13578-023-01136-x","article-title":"Liver organoid culture methods","volume":"13","author":"Hu","year":"2023","journal-title":"Cell Biosci"},{"key":"10.1016\/j.jceh.2026.103599_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202000893","article-title":"A chemically defined hydrogel for human liver Organoid culture","volume":"30","author":"Ye","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.jceh.2026.103599_bib66","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/acs.biomac.5b00041","article-title":"Self-assembled peptide amphiphile nanofibers and peg composite hydrogels as tunable ECM mimetic microenvironment","volume":"16","author":"Goktas","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jceh.2026.103599_bib67","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1002\/cpmb.58","article-title":"Human induced pluripotent stem cell production and expansion from blood using a non-integrating viral reprogramming vector","volume":"122","author":"Sharma","year":"2018","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1016\/j.jceh.2026.103599_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.mcb.2020.03.009","article-title":"Generation of multi-cellular human liver organoids from pluripotent stem cells","volume":"159","author":"Thompson","year":"2020","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.jceh.2026.103599_bib69","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1158\/1078-0432.CCR-25-1564","article-title":"Patient-derived organoids predict treatment response in metastatic colorectal cancer","volume":"31","author":"Smabers","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jceh.2026.103599_bib70","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s12015-024-10783-7","article-title":"Current landscape of iPSC haplobanks","volume":"20","author":"Escriba","year":"2024","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.jceh.2026.103599_bib71","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.3390\/cells10123280","article-title":"Optimized 3D culture of hepatic cells for Liver Organoid metabolic assays","volume":"10","author":"Gamboa","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jceh.2026.103599_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104955","article-title":"Dynamics of hepatocyte-cholangiocyte cell-fate decisions during liver development and regeneration","volume":"25","author":"Sahoo","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jceh.2026.103599_bib73","doi-asserted-by":"crossref","DOI":"10.3791\/63515","article-title":"Standardization and maintenance of 3D canine hepatic and intestinal organoid cultures for use in biomedical research","author":"Gabriel","year":"2022","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jceh.2026.103599_bib74","series-title":"Liver-On-A-Chip Model: An Alternative to Animal Models-Development Challenges and Future Perspectives","author":"Gulla","year":"2023"},{"key":"10.1016\/j.jceh.2026.103599_bib75","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/pharmaceutics15041300","article-title":"Microfluidic Liver-on-a-Chip for preclinical drug discovery","volume":"15","author":"Fu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jceh.2026.103599_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122627","article-title":"Microfluidic human physiomimetic liver model as a screening platform for drug induced liver injury","volume":"310","author":"Dey","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.jceh.2026.103599_bib77","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jceh.2026.103599_bib78","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1021\/ac300771z","article-title":"Comparison of biocompatibility and adsorption properties of different plastics for advanced microfluidic cell and tissue culture models","volume":"84","author":"van Midwoud","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.jceh.2026.103599_bib79","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biomaterials.2015.08.043","article-title":"A microfluidically perfused three dimensional human liver model","volume":"71","author":"Rennert","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jceh.2026.103599_bib80","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/biot.201300187","article-title":"Physiologically relevant organs on chips","volume":"9","author":"Yum","year":"2014","journal-title":"Biotechnol J"},{"key":"10.1016\/j.jceh.2026.103599_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/srep25329","article-title":"Isolation and co-culture of rat parenchymal and non-parenchymal liver cells to evaluate cellular interactions and response","volume":"6","author":"Bale","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2026.103599_bib82","article-title":"The dynamic effect of interactivity on customer engagement behavior through tie strength: evidence from live streaming commerce platforms","volume":"56","author":"Kang","year":"2021","journal-title":"Int J Inf Manag"},{"key":"10.1016\/j.jceh.2026.103599_bib83","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/cells9030590","article-title":"Hepatocyte injury and hepatic stem cell niche in the progression of non-alcoholic steatohepatitis","volume":"9","author":"Overi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jceh.2026.103599_bib84","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s42003-023-04710-8","article-title":"Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease","volume":"6","author":"Yang","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jceh.2026.103599_bib85","doi-asserted-by":"crossref","first-page":"54564","DOI":"10.1039\/C6RA10407J","article-title":"Integrated microfluidic system for cell co-culture and simulation of drug metabolism","volume":"6","author":"Jie","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.jceh.2026.103599_bib86","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1039\/D2LC00940D","article-title":"Opportunities and considerations for studying liver disease with microphysiological systems on a chip","volume":"23","author":"Otumala","year":"2023","journal-title":"Lab Chip"},{"key":"10.1016\/j.jceh.2026.103599_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202201435","article-title":"LivHeart: a multi organ-on-chip platform to study off-target cardiotoxicity of drugs upon liver metabolism","volume":"8","author":"Ferrari","year":"2023","journal-title":"Adv Mater Technol"},{"key":"10.1016\/j.jceh.2026.103599_bib88","doi-asserted-by":"crossref","DOI":"10.1063\/5.0106855","article-title":"Liver-on-a-chip: considerations, advances, and beyond","volume":"16","author":"Yang","year":"2022","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.jceh.2026.103599_bib89","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s41232-022-00248-0","article-title":"State-of-the-art liver disease research using liver-on-a-chip","volume":"42","author":"Deguchi","year":"2022","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.jceh.2026.103599_bib90","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41467-024-45710-4","article-title":"A microfluidic platform integrating functional vascularized organoids-on-chip","volume":"15","author":"Quintard","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jceh.2026.103599_bib91","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/ten.tea.2022.0197","article-title":"Tissue-engineered hepatocyte sheets supplemented with adipose-derived stem cells","volume":"29","author":"Suzushino","year":"2023","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.jceh.2026.103599_bib92","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/ten.tec.2023.0099","article-title":"Reproducible preparation of primary rat hepatocyte sheets using a thermoresponsive culture dish","volume":"29","author":"Kobayashi","year":"2023","journal-title":"Tissue Eng C Methods"},{"key":"10.1016\/j.jceh.2026.103599_bib93","first-page":"1","article-title":"The role of functional groups in tissue adhesives: a mini-review","author":"Esmaeili","year":"2025","journal-title":"Regener Eng Transl Med"},{"key":"10.1016\/j.jceh.2026.103599_bib94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13287-020-02080-0","article-title":"Improvement of the therapeutic capacity of insulin-producing cells trans-differentiated from human liver cells using engineered cell sheet","volume":"12","author":"Lee","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jceh.2026.103599_bib95","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s40472-017-0156-7","article-title":"Hepatocyte transplantation: cell sheet technology for liver cell transplantation","volume":"4","author":"Tatsumi","year":"2017","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.jceh.2026.103599_bib96","series-title":"Fabrication of Multilayered Hepatic Lobule Tissues Using Ca-alginate Hydrogel Platforms. 2017 IEEE 17th International Conference on Nanotechnology","first-page":"561","author":"Liu","year":"2017"},{"key":"10.1016\/j.jceh.2026.103599_bib97","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10529-017-2476-1","article-title":"Cell sheet-based multilayered liver tumor models for anti-cancer drug screening","volume":"40","author":"Yang","year":"2018","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.jceh.2026.103599_bib98","doi-asserted-by":"crossref","first-page":"60","DOI":"10.15825\/1995-1191-2022-4-60-72","article-title":"Treatment of chronic liver disease using cell-engineered constructs: morphofunctional characteristics","volume":"24","author":"Shagidulin","year":"2022","journal-title":"Russ J Transplantol Artif Organs"},{"key":"10.1016\/j.jceh.2026.103599_bib99","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/term.2102","article-title":"Fabrication of functional 3D hepatic tissues with polarized hepatocytes by stacking endothelial cell sheets in vitro","volume":"11","author":"Kim","year":"2017","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.jceh.2026.103599_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184004","article-title":"The potential of cell sheet technique on the development of hepatocellular carcinoma in rat models","volume":"12","author":"Alshareeda","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2026.103599_bib101","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/bit.28301","article-title":"3D-printed PLA\/Gel hybrid in liver tissue engineering: effects of architecture on biological functions","volume":"120","author":"Mirdamadi","year":"2023","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.jceh.2026.103599_bib102","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1039\/D1TB02686K","article-title":"An in vitro fibrotic liver lobule model through sequential cell-seeding of HSCs and HepG2 on 3D-printed poly(glycerol sebacate) acrylate scaffolds","volume":"10","author":"Hsiao","year":"2022","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.jceh.2026.103599_bib103","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/TP.0000000000004668","article-title":"The long road to develop custom-built livers: current status of 3D liver bioprinting","volume":"108","author":"Cross-Najafi","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2026.103599_bib104","first-page":"139","article-title":"Decellularized liver-regenerative 3D printing biomaterials for cell-based liver therapies via a designed procedure combining supercritical fluids with papain-containing reagents","volume":"33","author":"Huang","year":"2022","journal-title":"Bio Med Mater Eng"},{"key":"10.1016\/j.jceh.2026.103599_bib105","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1038\/s41598-022-11641-7","article-title":"Modelling liver cancer microenvironment using a novel 3D culture system","volume":"12","author":"Al Hrout","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2026.103599_bib106","first-page":"184","article-title":"Bioengineered 3D electrospun nanofibrous scaffold with human liver cells to study alcoholic liver disease in vitro","volume":"13","author":"Das","year":"2021","journal-title":"Integr Biol"},{"key":"10.1016\/j.jceh.2026.103599_bib107","article-title":"Development of lumen-based perfusable 3D liver in vitro model using single-step bioprinting with composite bioinks","volume":"21","author":"Maji","year":"2023","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.jceh.2026.103599_bib108","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.3390\/molecules28093683","article-title":"Advancements in research on constructing physiological and pathological liver models and their applications utilizing bioprinting technology","volume":"28","author":"Ming","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jceh.2026.103599_bib109","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/mi14040878","article-title":"3D bioprinting of an endothelialized liver lobule-like construct as a tumor-scale drug screening platform","volume":"14","author":"Fan","year":"2023","journal-title":"Micromachines"},{"key":"10.1016\/j.jceh.2026.103599_bib110","doi-asserted-by":"crossref","first-page":"721","DOI":"10.18063\/ijb.721","article-title":"3D-Printed multi-material liver model with simultaneous mechanical and radiological tissue-mimicking features for improved realism","volume":"9","author":"Jaksa","year":"2023","journal-title":"Int J Bioprint"},{"key":"10.1016\/j.jceh.2026.103599_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/pat.70152","article-title":"Three-dimensional printing applications for bone tissue engineering: a review","volume":"36","author":"Jalise","year":"2025","journal-title":"Polym Adv Technol"},{"key":"10.1016\/j.jceh.2026.103599_bib112","article-title":"Biocompatibility evaluation of antioxidant cocktail loaded gelatin methacrylamide as bioink for extrusion-based 3D bioprinting","volume":"18","author":"Velayudhan","year":"2023","journal-title":"Biomed Mater"},{"key":"10.1016\/j.jceh.2026.103599_bib113","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/acd872","article-title":"Internally crosslinked alginate-based bioinks for the fabrication of in vitro hepatic tissue models","volume":"15","author":"Guagliano","year":"2023","journal-title":"Biofabrication"},{"key":"10.1016\/j.jceh.2026.103599_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213499","article-title":"3D bioprinted liver tissue and disease models: current advances and future perspectives","volume":"152","author":"Sun","year":"2023","journal-title":"Biomater Adv"},{"key":"10.1016\/j.jceh.2026.103599_bib115","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1021\/acsabm.3c00032","article-title":"A unification of nanotopography and extracellular matrix in electrospun scaffolds for bioengineered hepatic models","volume":"6","author":"Gao","year":"2023","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.jceh.2026.103599_bib116","article-title":"Decellularized liver nanofibers enhance and stabilize the long-term functions of primary human hepatocytes in vitro","volume":"12","author":"Liu","year":"2023","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.jceh.2026.103599_bib117","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/biomimetics7040149","article-title":"Evolution of electrospinning in liver tissue engineering","volume":"7","author":"Vasudevan","year":"2022","journal-title":"Biomimetics"},{"key":"10.1016\/j.jceh.2026.103599_bib118","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/jbm.b.35115","article-title":"Rat liver ECM incorporated into electrospun polycaprolactone scaffolds as a platform for hepatocyte culture","volume":"110","author":"Bate","year":"2022","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.jceh.2026.103599_bib119","first-page":"316","article-title":"[Non-alcoholic steatohepatitis (NASH) : a model of metabolic inflammation (<<metaflammation>>)]","volume":"77","author":"Scheen","year":"2022","journal-title":"Rev Med Liege"},{"key":"10.1016\/j.jceh.2026.103599_bib120","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s42003-021-02616-x","article-title":"Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system","volume":"4","author":"Kostrzewski","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.jceh.2026.103599_bib121","first-page":"74","article-title":"Non-alcoholic steatohepatitis: an update in pathophysiology, diagnosis and therapy","volume":"11","author":"Khedmat","year":"2011","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jceh.2026.103599_bib122","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab296f","article-title":"In vitro disease models 4.0 via automation and high-throughput processing","volume":"11","author":"Eggert","year":"2019","journal-title":"Biofabrication"},{"key":"10.1016\/j.jceh.2026.103599_bib123","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/cimb47010007","article-title":"Advanced in vitro models for preclinical drug safety: recent progress and prospects","volume":"47","author":"Nair","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.jceh.2026.103599_bib124","series-title":"Biomedical Product and Materials Evaluation","first-page":"555","article-title":"Engineered in vitro models: mimicking in vivo physiology","author":"Shah","year":"2022"},{"key":"10.1016\/j.jceh.2026.103599_bib125","first-page":"202","article-title":"Microfluidic models of atherosclerosis: replacing animal testing with on-chip technology","volume":"2","author":"Mosadegh","year":"2017","journal-title":"Adv Tissue Eng Regen Med Open Access"},{"key":"10.1016\/j.jceh.2026.103599_bib126","series-title":"In Vitro Micro-tissue and-organ Models for Toxicity Testing","author":"Li","year":"2011"},{"key":"10.1016\/j.jceh.2026.103599_bib127","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/10915818221139471","article-title":"Comparison of Rat hepatocyte 2D-Monocultures and hepatocytes non-parenchymal cell Co-Cultures for assessing chemical toxicity","volume":"42","author":"Stefanowicz","year":"2023","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.jceh.2026.103599_bib128","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/term.2099","article-title":"Three-dimensional co-culture of human hepatocytes and mesenchymal stem cells: improved functionality in long-term bioreactor cultures","volume":"11","author":"Rebelo","year":"2017","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.jceh.2026.103599_bib129","first-page":"1","article-title":"An accessible 3D HepG2\/C3A liver spheroid model supporting the complete intrahepatocytic lifecycle of Plasmodium falciparum","author":"Caygill","year":"2024","journal-title":"Parasitology"},{"key":"10.1016\/j.jceh.2026.103599_bib130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/ten.tea.2019.0262","article-title":"HepaRG self-assembled spheroids in alginate beads meet the clinical needs for bioartificial liver","volume":"26","author":"Pasqua","year":"2020","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.jceh.2026.103599_bib131","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3389\/fphar.2019.01093","article-title":"Comprehensive evaluation of organotypic and microphysiological liver models for prediction of drug-induced liver injury","volume":"10","author":"Zhou","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jceh.2026.103599_bib132","doi-asserted-by":"crossref","first-page":"58","DOI":"10.38001\/ijlsb.1493377","article-title":"Advancements in 3D in vitro cell culture systems: enhancing drug pharmacokinetics and toxicity assessment in pharmaceutical development","volume":"8","author":"Bayraktaro\u011flu","year":"2024","journal-title":"Int J Life Sci Biotechnol"},{"key":"10.1016\/j.jceh.2026.103599_bib133","article-title":"Integrating bioartificial liver systems and liver organoids for enhancing tertiary prevention of liver diseases","author":"Addissouky","year":"2025","journal-title":"Review"},{"key":"10.1016\/j.jceh.2026.103599_bib134","series-title":"Microfluidics and Multi Organs on Chip","first-page":"695","article-title":"Building human In vitro 3D models to replace animal studies during drug discovery research: scientific, ethical and regulatory considerations","author":"Vangala","year":"2022"},{"key":"10.1016\/j.jceh.2026.103599_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214288","article-title":"A functional human liver tissue model: 3D bioprinted co-culture discoids","volume":"173","author":"Subramaniam","year":"2025","journal-title":"Biomater Adv"},{"key":"10.1016\/j.jceh.2026.103599_bib136","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10529-017-2476-1","article-title":"Cell sheet-based multilayered liver tumor models for anti-cancer drug screening","volume":"40","author":"Yang","year":"2018","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.jceh.2026.103599_bib137","doi-asserted-by":"crossref","DOI":"10.1177\/20417314241286092","article-title":"Scaffold-mediated liver regeneration: a comprehensive exploration of current advances","volume":"15","author":"Bhatt","year":"2024","journal-title":"J Tissue Eng"},{"key":"10.1016\/j.jceh.2026.103599_bib138","series-title":"Narrowing the Translational Gap in Metabolic dysfunction-associated Steatotic Liver Disease (MASLD) Drug Development","author":"Kemas","year":"2025"},{"key":"10.1016\/j.jceh.2026.103599_bib139","series-title":"Liver Viscosity Decreases Before the Onset of Fibrosis in Metabolic Dysfunction-Associated Steatohepatitis (MASH)","author":"Safraou","year":"2025"},{"key":"10.1016\/j.jceh.2026.103599_bib140","article-title":"Active role of the immune system in metabolic dysfunction-associated steatotic liver disease","volume":"12","author":"Mori","year":"2024","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.jceh.2026.103599_bib141","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2026.103599_bib142","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41575-024-00955-8","article-title":"A roadmap for clinical trials in MASH-related compensated cirrhosis","volume":"21","author":"Peric\u00e0s","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103599_bib143","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fimmu.2014.00177","article-title":"Role of innate immune response in non-alcoholic fatty liver disease: metabolic complications and therapeutic tools","volume":"5","author":"Meli","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2026.103599_bib144","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s43066-025-00459-3","article-title":"Exploring animal models and in vitro models for liver diseases: a review","volume":"15","author":"Bhatt","year":"2025","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.jceh.2026.103599_bib145","doi-asserted-by":"crossref","DOI":"10.20517\/mtod.2025.163","article-title":"Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy","volume":"5","author":"Fu","year":"2025","journal-title":"Metabol Target Organ Damage"},{"key":"10.1016\/j.jceh.2026.103599_bib146","series-title":"Modeling the Pathogenic Mechanisms of Metabolic dysfunction-associated Steatotic Liver Disease (MASLD) Progression Using Specialized Human Multicellular 3D Organotypic Models","author":"Gan\u00e7o","year":"2025"},{"key":"10.1016\/j.jceh.2026.103599_bib147","series-title":"The Role of Dietary Cholesterol in Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Action of Gut Microbiota","author":"Hermanson","year":"2025"},{"key":"10.1016\/j.jceh.2026.103599_bib148","series-title":"A Custom PDMS-based Single-Channel Microfluidic Platform for Modeling Traumatic Brain Injury in Vitro","author":"Badeaux","year":"2025"},{"key":"10.1016\/j.jceh.2026.103599_bib149","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.7150\/thno.81785","article-title":"Strategies for improving the 3D printability of decellularized extracellular matrix bioink","volume":"13","author":"Zhang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.jceh.2026.103599_bib150","first-page":"1097","article-title":"Metabolic reprograming of immune cells in MASH","volume":"10","author":"Ma","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103599_bib151","article-title":"Direct contact between iPSC-derived macrophages and hepatocytes drives reciprocal acquisition of Kupffer cell identity and hepatocyte maturation","author":"Lee","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jceh.2026.103599_bib152","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/ten.teb.2015.0376","article-title":"The host immune response to tissue-engineered organs: current problems and future directions","volume":"22","author":"Wiles","year":"2016","journal-title":"Tissue Eng Part B"},{"key":"10.1016\/j.jceh.2026.103599_bib153","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1109\/RBME.2024.3505073","article-title":"Immunomechanobiology: engineering the activation and function of immune cells with the mechanical signal of fluid shear stress","volume":"18","author":"Sarna","year":"2024","journal-title":"IEEE Rev Biomed Eng"},{"key":"10.1016\/j.jceh.2026.103599_bib154","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41423-025-01298-3","article-title":"Liver macrophages: development, dynamics, and functions","volume":"22","author":"Nusse","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jceh.2026.103599_bib155","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1038\/s41467-022-34241-5","article-title":"Understanding fibrosis pathogenesis via modeling macrophage-fibroblast interplay in immune-metabolic context","volume":"13","author":"Setten","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jceh.2026.103599_bib156","article-title":"Advances in microfluidic technologies in organoid research","volume":"13","author":"Liu","year":"2024","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.jceh.2026.103599_bib157","article-title":"Precision spatial control of tumor-stroma interactions in cancer models via 3D bioprinting for advanced research and therapy","volume":"35","author":"Li","year":"2025","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.jceh.2026.103599_bib158","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s10439-025-03779-y","article-title":"Lessons Learned from Liver-on-Chip Platform: ZS Razavi et al","volume":"53","author":"Razavi","year":"2025","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.jceh.2026.103599_bib159","article-title":"Rethinking matrigel: the complex journey to matrix alternatives in organoid culture","volume":"12","author":"Wolff","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jceh.2026.103599_bib160","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3390\/polym15081926","article-title":"The additive manufacturing approach to polydimethylsiloxane (PDMS) microfluidic devices: review and future directions","volume":"15","author":"Tony","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.jceh.2026.103599_bib161","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12673","article-title":"Effects of impaired microvascular flow regulation on metabolism-perfusion matching and organ function","volume":"28","author":"Roy","year":"2021","journal-title":"Microcirculation"},{"key":"10.1016\/j.jceh.2026.103599_bib162","series-title":"Versatile multi-component (Bio) Ink Platform for Advanced Biofabrication","author":"Perin","year":"2024"},{"key":"10.1016\/j.jceh.2026.103599_bib163","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41575-024-00938-9","article-title":"Envisioning how to advance the MASH field","volume":"21","author":"Allen","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103599_bib164","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jcmgh.2023.01.013","article-title":"Engineered platforms for maturing pluripotent stem cell-derived liver cells for disease modeling","volume":"15","author":"Yuan","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103599_bib165","doi-asserted-by":"crossref","first-page":"10167","DOI":"10.1021\/acsami.2c00312","article-title":"Mimicking native liver lobule microarchitecture in vitro with parenchymal and non-parenchymal cells using 3D bioprinting for drug toxicity and drug screening applications","volume":"14","author":"Janani","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jceh.2026.103599_bib166","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.3390\/app12105029","article-title":"Three-dimensional-bioprinted liver chips and challenges","volume":"12","author":"Dabbagh","year":"2022","journal-title":"Appl Sci"},{"key":"10.1016\/j.jceh.2026.103599_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.937595","article-title":"High-throughput bioengineering of homogenous and functional human-induced pluripotent stem cells-derived liver organoids via micropatterning technique","volume":"10","author":"Xu","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jceh.2026.103599_bib168","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/pharmaceutics15010054","article-title":"Current research trends in the application of In vitro three-dimensional models of liver cells","volume":"15","author":"Yun","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jceh.2026.103599_bib169","series-title":"Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine. Seminars in Liver Disease. Vol 41","first-page":"368","author":"Kukla","year":"2021"},{"key":"10.1016\/j.jceh.2026.103599_bib170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13036-017-0081-4","article-title":"Bioengineering considerations in liver regenerative medicine","volume":"11","author":"Ogoke","year":"2017","journal-title":"J Biol Eng"},{"key":"10.1016\/j.jceh.2026.103599_bib171","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40360-025-01074-z","article-title":"A human liver organoids-on-chip for the assessment of drug-induced liver injury","volume":"27","author":"Chen","year":"2026","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jceh.2026.103599_bib172","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s43856-022-00209-1","article-title":"Performance assessment and economic analysis of a human Liver-chip for predictive toxicology","volume":"2","author":"Ewart","year":"2022","journal-title":"Commun Med"},{"key":"10.1016\/j.jceh.2026.103599_bib173","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.xphs.2020.02.021","article-title":"Three-dimensional spheroids with primary human liver cells and differential roles of kupffer cells in drug-induced liver injury","volume":"109","author":"Li","year":"2020","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.jceh.2026.103599_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1378371","article-title":"Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone","volume":"15","author":"Roux","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jceh.2026.103599_bib175","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/s41598-024-55438-2","article-title":"Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model","volume":"14","author":"Kostadinova","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2026.103599_bib176","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2025.1536756","article-title":"Perspective: how complex in vitro models are addressing the challenges of predicting drug-induced liver injury","volume":"5","author":"Taylor","year":"2025","journal-title":"Front Drug Discov"},{"key":"10.1016\/j.jceh.2026.103599_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2024.101046","article-title":"Advancements in microphysiological systems: exploring organoids and organ-on-a-chip technologies in drug development -focus on pharmacokinetics related organs","volume":"60","author":"Kimura","year":"2025","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.jceh.2026.103599_bib178","doi-asserted-by":"crossref","DOI":"10.1093\/toxres\/tfae044","article-title":"New approach methodologies (NAMs): identifying and overcoming hurdles to accelerated adoption","volume":"13","author":"Sewell","year":"2024","journal-title":"Toxicol Res"},{"key":"10.1016\/j.jceh.2026.103599_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109199","article-title":"Complex or not too complex? One size does not fit all in next generation microphysiological systems","volume":"27","author":"Bersini","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jceh.2026.103599_bib180","article-title":"Modeling familial MASH by iPSC-Hepatocytes","author":"Esteva-Font","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.jceh.2026.103599_bib181","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2174\/1568026623666230714113808","article-title":"Emerging therapies and therapeutic targets for composite liver disease: NASH","volume":"23","author":"Sobhia","year":"2023","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jceh.2026.103599_bib182","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3748\/wjg.v29.i1.75","article-title":"Emerging novel targets for nonalcoholic fatty liver disease treatment: evidence from recent basic studies","volume":"29","author":"Wang","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103599_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101730","article-title":"Interdisciplinary advances reshape the delivery tools for effective NASH treatment","volume":"73","author":"Chen","year":"2023","journal-title":"Mol Metabol"},{"key":"10.1016\/j.jceh.2026.103599_bib184","first-page":"1397","article-title":"NASH drug development: seeing the light at the end of the tunnel?","volume":"11","author":"Chen","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2026.103599_bib185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.jceh.2026.103599_bib186","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012185","article-title":"The emerging role of extracellular vesicles and autophagy machinery in NASH-future Horizons in NASH management","volume":"23","author":"Trifylli","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103599_bib187","series-title":"Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update. Seminars in Liver Disease. Vol 42","first-page":"379","author":"Chew","year":"2022"},{"key":"10.1016\/j.jceh.2026.103599_bib188","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.3390\/cancers15143744","article-title":"Establishment of novel mouse model of dietary NASH rapidly progressing into liver cirrhosis and tumors","volume":"15","author":"Zheng","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jceh.2026.103599_bib189","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2021-326874","article-title":"Current therapies and new developments in NASH","volume":"71","author":"Dufour","year":"2022","journal-title":"Gut"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:45:01Z","timestamp":1791323101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688326001313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":189,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0973688326001313"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103599","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three Dimensional Biomimetic Liver Models to Reconstitute Metabolic Dysfunction-Associated Steatohepatitis (MASH) In Vitro: Hope and Reality","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103599"}}